Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round)and crowd-funding platform...

OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of $100 million. The money will be invested in “urgent technological solutions for the medical, business, educational and social needs triggered...